4.6 Article

A data-driven evaluation of the size and content of expanded carrier screening panels

期刊

GENETICS IN MEDICINE
卷 21, 期 9, 页码 1931-1939

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/s41436-019-0466-5

关键词

genetic testing; expanded carrier screening; clinical utility; clinical guidelines; clinical detection rate

资金

  1. Myriad Women's Health

向作者/读者索取更多资源

Purpose: The American College of Obstetricians and Gynecologists (AGOG) proposed seven criteria for expanded carrier screening (ECS) panel design. To ensure that screening for a condition is sufficiently sensitive to identify carriers and reduce residual risk of noncarriers, one criterion requires a per-condition carrier rate greater than 1 in 100. However, it is unestablished whether this threshold corresponds with a loss in clinical detection. The impact of the proposed panel design criteria on at-risk couple detection warrants data-driven evaluation. Methods: Carrier rates and at-risk couple rates were calculated in 56,281 patients who underwent a 176-condition ECS and were evaluated for panels satisfying various criteria. Condition-specific clinical detection rates were estimated via simulation. Results: Different interpretations of the 1-in-100 criterion have variable impact: a compliant panel would include between 3 and 38 conditions, identify 11-81% fewer at-risk couples, and detect 36-79% fewer carriers than a 176-condition panel. If the carrier rate threshold must be exceeded in all ethnicities, ECS panels would lack prevalent conditions like cystic fibrosis. Simulations suggest that the clinical detection rate remains >84% for conditions with carrier rates as low as 1 in 1000. Conclusion: The 1-in-100 criterion limits at-risk couple detection and should be reconsidered.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据